Concepedia

Publication | Open Access

The Combination PARP Inhibitor Olaparib With Temozolomide in an Experimental Glioblastoma Model

DOIFull Paper Access

20

Citations

19

References

2021

Year

Kihwan Hwang, Jin‐Han Lee, Sang Ho Kim, Kyeong-O Go, So Young Ji, Jung Ho Han, Chae‐Yong Kim
In Vivo

Abstract

The combination of the PARP inhibitor olaparib with temozolomide could be promising candidates for combination therapy of glioblastoma regardless of the MGMT promoter methylation status.

References

YearCitations

Page 1